Vigadrone

Active Ingredient(s): Vigabatrin
FDA Approved: * June 21, 2018
Pharm Company: * AUCTA PHARMS
Category: Anticonvulsant

Vigabatrin, brand name Sabril, is a medication used to treat epilepsy. It became available as a generic medication in 2019.[1] It works by inhibiting the breakdown of γ-aminobutyric acid (GABA). It is also known as γ-vinyl-GABA, and is a structural analogue of GABA, but does not bind to GABA receptors.[2] Contents 1 Medical uses 1.1 Epilepsy 1.2 Others 2 Adverse effects 2.1 Central nervous system 2.2 Gastrointestinal 2.3 Body as a whole 2.4 Tera... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vigadrone 50 mg/ml Oral Powder, for Solution

NDC: 0245-0556

Labeler:

Upsher-smith Laboratories, LLC

Vigadrone 500 mg Oral Tablet

NDC: 0245-6001

Labeler:

Upsher-smith Laboratories, LLC

Vigadrone 50 mg/ml Oral Powder, for Solution

NDC: 73289-0002

Labeler:

Aucta Pharmaceuticals, Inc.

Vigadrone 50 mg/ml Oral Powder, for Solution

NDC: 73289-0003

Labeler:

Aucta Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients